Sun Pharmaceutical Industries Share Price Today - Live Blog for July 18, 2025

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.19%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,691.30, and market participants are assessing the implications. The stock has a PE ratio of 37.3900, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.08%, with the current market value at ₹1,693.50 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

With a -0.01% decrease, Sun Pharmaceutical Industries Ltd's share price is currently at ₹1,694.80. This development raises questions about the factors behind the decline. The stock's PE ratio is 37.3900, while the industry PE is 35.9007.

Sun Pharmaceutical Industries Ltd shares saw a -0.15% decrease, reaching a current market price of ₹1,694.55. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 37.3900, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.10%, and as of now, it's trading at ₹1,694.20 per share. This upward trajectory is attracting keen interest from investors.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.12% increase in its share price and is currently trading at ₹1,693.40. This remarkable performance has caught the eye of investors.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.12%, and it is currently trading at ₹1,693.40. Additionally, the stock maintains a PE ratio of 37.3900, while the industry PE is 35.9007.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.09%, a development that warrants careful analysis. Presently trading at ₹1,691.40, investors are assessing whether this presents an opportunity or a risk.

Sun Pharmaceutical Industries Ltd experienced a -0.22% dip in its share price and is currently trading at ₹1,692.70. The stock has a PE ratio of 37.3900, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd experienced a -0.22% downturn in its share price, and it's currently trading at ₹1,692.70. This situation is generating interest among value investors who are evaluating the stock's potential.

Following a noteworthy 0.06% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,696.50. When it comes to valuation, this stock has a PE ratio of 37.3900, with the industry PE ratio at 35.9007.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.16%, with its current market value per share resting at ₹1,697.90. This development highlights the stock's appeal to investors.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.16% surge in its share price and is presently trading at ₹1,697.90, captivating the attention of market participants.

Sun Pharmaceutical Industries Ltd stock remained static, maintaining its position at ₹1,695.25. The stock has a PE ratio of 37.3900, an ROE of 15.1334%, and a debt to equity ratio of 0.0327.

With a remarkable 0.17% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,692.20. Notably, this stock has a Price-to-Earnings (PE) ratio of 37.3900, while the industry's PE ratio is 35.9007.

Sun Pharmaceutical Industries Ltd's shares saw an increase of 0.17%, reaching the current market price of ₹1,692.20. This development underscores the stock's growing popularity.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.02% surge in its share price and is presently trading at ₹1,689.70. The increased investor interest is driving this surge.

With a -0.06% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,689.35. The stock is currently trading at a PE of 37.3900, while the industry PE is 35.9007, prompting investors to assess its value proposition.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.04%, a development that warrants careful analysis. Presently trading at ₹1,690.40, investors are assessing whether this presents an opportunity or a risk.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.02% uptick, and they are currently valued at ₹1,691.55, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

With a remarkable 0.14% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,692.80. Notably, this stock has a Price-to-Earnings (PE) ratio of 37.3900, while the industry's PE ratio is 35.9007.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.12% drop, and it's now trading at ₹1,691.55 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

With a -0.01% decrease, Sun Pharmaceutical Industries Ltd's share price is currently at ₹1,696.30. This development raises questions about the factors behind the decline. The stock's PE ratio is 37.3900, while the industry PE is 35.9007.

Sun Pharmaceutical Industries Ltd observed a -0.11% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,697.15. The stock has a PE ratio of 37.3900, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's shares saw an increase of 0.01%, reaching the current market price of ₹1,697.00. This development underscores the stock's growing popularity.

Sun Pharmaceutical Industries Ltd experienced a -0.89% downturn in its share price, and it's currently trading at ₹1,696.45. This situation is generating interest among value investors who are evaluating the stock's potential.